-
TOLERABILITY PATIENT-REPORTED OUTCOMES IN FDA ONCOLOGY NEW DRUG APPROVALS (2021-2025)
Feb 25, 2026, 14:41 PM -
REAL-WORLD COMPARATIVE OUTCOMES AND COSTS OF SGLT-2 INHIBITORS VERSUS DPP-4 INHIBITORS IN TYPE 2 DIABETES PATIENTS WITH HEART FAILURE
Feb 25, 2026, 14:41 PM -
A LIFETIME COST-UTILITY ANALYSIS OF IGLARLIXI VERSUS IDEGASP IN TYPE 2 DIABETES IN TURKIYE
Feb 25, 2026, 14:41 PM -
ARTIFICIAL INTELLIGENCE (AI) IN ONCOLOGY HEALTH TECHNOLOGY ASSESSMENT (HTA): CURRENT APPLICATIONS, LIMITATIONS, AND IMPLICATIONS FOR LIVING-HTA
Feb 25, 2026, 14:41 PM -
DIGITAL TRANSFORMATION AND EFFICIENCY: A CROSS-COUNTRY SEM PROTOCOL FOR HEALTH SYSTEM PERFORMANCE
Feb 25, 2026, 14:41 PM -
POSTURAL CORRECTION IN PRIMARY SCHOOL CHILDREN AND THE EFFECTS OF SCHOOL BACKPACKS ON POSTURE
Feb 25, 2026, 14:41 PM -
HEALTHCARE COST SAVINGS FROM THE AUTOMATED IDENTIFICATION OF ADMINISTRATIVE INEFFICIENCIES IN PATIENTS WITH HIGH-COST CHRONIC DISEASES
Feb 25, 2026, 14:41 PM -
ROBOTIC-ASSISTED PYELOPLASTY USING THE DA VINCI SURGICAL SYSTEMS COMPARED TO LAPAROSCOPIC OR OPEN APPROACH: A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS
Feb 25, 2026, 14:41 PM -
A COMPARISON OF DIRECT MEDICAL COSTS IN VERTEBROPLASTY AND KYPHOPLASTY IN JAPAN AND IMPLICATIONS FOR IMPACTS ON THE BUDGET
Feb 25, 2026, 14:41 PM -
GLOBAL PREVALENCE AND CLINICAL PRESENTATION OF ALOPECIA AREATA: A SYSTEMATIC REVIEW
Feb 25, 2026, 14:41 PM -
RELATIONSHIP BETWEEN IMPROVEMENT IN LUNG FUNCTION AND SYMPTOMS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH DUPILUMAB
Feb 25, 2026, 14:41 PM -
SOCIETAL IMPACT ASSESSMENT OF OFATUMUMAB IN RELAPSING-REMITTING MULTIPLE SCLEROSIS: A 5-PILLAR ANALYSIS FROM A SOCIETAL PERSPECTIVE
Feb 25, 2026, 14:41 PM -
A SYSTEMATIC REVIEW OF ONCOLYTIC VIRUSES AND GENE THERAPIES FOR RETINOBLASTOMA IN CHILDREN
Feb 25, 2026, 14:41 PM -
BUDGET IMPACT OF INTRODUCING PIRTOBRUTINIB AFTER COVALENT BRUTON TYROSINE KINASE INHIBITOR THERAPY IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA IN THE US
Feb 25, 2026, 14:41 PM -
COMPARATIVE EVALUATION OF SUBJECTIVE SLEEP QUALITY AND INSOMNIA ACROSS PSYCHIATRIC DISORDERS: EVIDENCE FROM PATIENT-REPORTED OUTCOME MEASURES
Feb 25, 2026, 14:41 PM -
DIVERSITY IN CLINICAL TRIALS: A REVIEW OF DRUGS APPROVED BY THE FDA IN 2024
Feb 25, 2026, 14:41 PM -
APPLYING THE POMELO BEST PRACTICES FRAMEWORK TO ENHANCE REPORTING STANDARDS IN PATIENT LISTENING STUDIES FROM SOCIAL MEDIA
Feb 25, 2026, 14:41 PM -
COMPARING TEST-RETEST RELIABILITY AND RESPONSIVENESS OF EQ-5D-5L WITH FOUR BOLT-ONS, PROMIS-29 AND SKINDEX-16 IN PSORIASIS AND ATOPIC DERMATITIS PATIENTS
Feb 25, 2026, 14:41 PM -
BASELINE (UNTREATED) RISK OF HOSPITALIZATION AND MORTALITY IN PATIENTS WITH SPECIFIC COMORBID HIGH-RISK CONDITIONS WHO ARE ELIGIBLE FOR NIRMATRELVIR/RITONAVIR TREATMENT: A SYSTEMATIC LITERATURE REVIEW EXPANSION STUDY
Feb 25, 2026, 14:41 PM -
EXAMINING PATIENT AND TUMOR CHARACTERISTICS ASSOCIATED WITH THE RECEIPT OF NEOADJUVANT CHEMOTHERAPY (NAC) AMONG WOMEN WITH EARLY-STAGE HORMONE RECEPTOR-POSITIVE BREAST CANCER
Feb 25, 2026, 14:41 PM
